Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.

Nature cell biology | 2012

Fbxw7α is a member of the F-box family of proteins, which function as the substrate-targeting subunits of SCF (Skp1/Cul1/F-box protein) ubiquitin ligase complexes. Using differential purifications and mass spectrometry, we identified p100, an inhibitor of NF-κB signalling, as an interactor of Fbxw7α. p100 is constitutively targeted in the nucleus for proteasomal degradation by Fbxw7α, which recognizes a conserved motif phosphorylated by GSK3. Efficient activation of non-canonical NF-κB signalling is dependent on the elimination of nuclear p100 through either degradation by Fbxw7α or exclusion by a newly identified nuclear export signal in the carboxy terminus of p100. Expression of a stable p100 mutant, expression of a constitutively nuclear p100 mutant, Fbxw7α silencing or inhibition of GSK3 in multiple myeloma cells with constitutive non-canonical NF-κB activity results in apoptosis both in cell systems and xenotransplant models. Thus, in multiple myeloma, Fbxw7α and GSK3 function as pro-survival factors through the control of p100 degradation.

Pubmed ID: 22388891 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM057587-14
  • Agency: NCI NIH HHS, United States
    Id: T32 CA009161
  • Agency: NCI NIH HHS, United States
    Id: P30 CA016087
  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL007151
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM057587
  • Agency: NCI NIH HHS, United States
    Id: R21 CA161108-01
  • Agency: NCI NIH HHS, United States
    Id: R21-CA161108
  • Agency: NCI NIH HHS, United States
    Id: R37 CA076584-13
  • Agency: NCI NIH HHS, United States
    Id: R21 CA161108
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM057587-13
  • Agency: NIGMS NIH HHS, United States
    Id: R01-GM057587
  • Agency: NCI NIH HHS, United States
    Id: R37 CA076584-14
  • Agency: NCI NIH HHS, United States
    Id: R37-CA076584
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NHLBI NIH HHS, United States
    Id: 5T32HL007151-33
  • Agency: NCI NIH HHS, United States
    Id: R37 CA076584

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


New York University School of Medicine Langone Health Microscopy Laboratory Core Facility (tool)

RRID:SCR_017934

Core offers comprehensive light and electron microscopy technologies. Our scientists use light microscopes and electron microscopes at resolutions ranging from centimeters to angstroms, providing clear and detailed images.We assist at every stage of your experiment, offering research-design consultation and instrument training, as well as guidance in study execution, analysis, and presentation for publication.

View all literature mentions